en · de · es · fr · pt
cardarine-notes.peptides3626.com › Guide › Cardarine As Investigational Pparδ Agonist — Evidence Review

Cardarine As Investigational Pparδ Agonist — Evidence Review

By Editorial Desk · published 2025-08-13 · last reviewed 2025-09-28 · Guide

The short version of PPARδ agonist fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-09-28 and is reviewed periodically as new material appears.

Cardarine as Investigational PPARδ Agonist

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Mechanism and Laboratory Detection

GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.

Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.

Cardarine at a glance

PropertyValueNotes
Common synonymsGW501516, GW-501516, GW 501516, endurobolNames vary in research and anti-doping documents.
Chemical classSynthetic PPARδ agonistSmall-molecule nuclear receptor ligand.
CAS Registry Number317318-70-0Identifier commonly associated with GW501516.
AppearanceWhite to off-white powderTypical for purified research material.
SolubilityLow in water; soluble in DMSO and ethanolOrganic solvents are common for laboratory stock solutions.

Identity and Pharmacological Classification

Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Related pages on this site

Mechanism and Detection

Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.

Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.

Reference notes

=== Neurotoxicity === Laboratory studies in rats indicate that ibogaine at high doses may cause degeneration of Purkinje cells in the cerebellum. This also occurred with the related drug harmaline. However, subsequent research found no evidence of this neurotoxicity with ibogaine in a primate. In limited human research, neuropathological examination revealed no evidence of neuronal degenerative changes in an adult female patient who had received four separate doses of ibogaine ranging between 10 and 30 mg/kg over a 15-month interval. A published series of fatalities associated with ibogaine ingestion also found no evidence for consistent neurotoxicity.

Duterte's father, Vicente, died in 1968 while his mother, Soledad, died on February 4, 2012, at the age of 95. In 1973, Duterte married Elizabeth Zimmerman, a flight attendant of German American descent who traces her roots in Tuburan, Cebu. They have three children (from eldest to youngest): Paolo ("Pulong"), Sara ("Inday Sara") and Sebastian ("Baste"). In the 1990s, his son Paolo left the family for more than five years after having a son (Omar Vincent) with Lovelie Sangkola in 1994, which Duterte acknowledged to be "[o]ne of my sad events in my life". Sara and Paolo both entered politics in 2007 and 2008 respectively, while Baste, with no interest in politics, initially concentrated on business and surfing but eventually ran and won as vice mayor of Davao City in 2019. Sara was elected as Vice President in 2022. Duterte has been publicly open about his infidelity while married to Zimmerman and cited it as the reason for his failed marriage. According to newspaper columnist Ramon Tulfo, Duterte's various alleged partners included "a then agriculture undersecretary, a governor of a province, a local TV newscaster and a policewoman", with Duterte himself admitting in 2016 to having multiple girlfriends such as a cosmetics worker in a shopping mall and a cashier. In 1998, Zimmerman filed a petition in the Regional Trial Court of Pasig to nullify her marriage. Duterte never appeared in court and did not contest Zimmerman's petition. Two years later, the court decided in her favor, ending the 27-year marriage of Duterte and Zimmerman.

==== Eva Kaili ==== Kaili denied any wrongdoing in the controversy. Her lawyers appeared on Greek TV stating that she "declares her innocence and that she has nothing to do with bribery from Qatar". Kaili's lawyers were also critical of her arrest as a "gross overreach of judicial power". They maintain that Kaili was in a state of shock, fear and confusion during her first interview and that she was not provided with an interpreter for the interview. According to her lawyers, it took a week for Kaili to be in "good enough psychological condition to be fully aware of what she was saying". Kaili reportedly felt "very troubled" and betrayed by her partner, Giorgi, according to her lawyers. Kaili has accused the Belgian authorities of "inhuman" behavior due to the Belgian authorities refusal to allow her to see her daughter in person or via Skype. Kaili said: "I am being tortured, this is so unfair that I cannot stand it, and I am breaking down. What is the problem with my little girl, why are they keeping her away from me?". The following day a three-hour meeting between Kaili and her daughter was authorised. The court decided on 16 February 2023 to keep Kaili in detention for another two months. Kaili had changed her Belgian lawyer from André Risopoulo to Sven Mary some time before the hearing. Mary had "represented one of the terrorists behind the 2015 Paris attacks". Kaili was released from pre-trial detention with an electronic bracelet on 14 April 2023 and, throughout the process, has continued to deny all charges against her.

Sources: en.wikipedia.org

Reference notes

The 4n+1 chain of neptunium-237 is commonly called the "neptunium series" or "neptunium cascade". In this series, only two of the isotopes involved are found naturally in significant quantities, namely the final two: bismuth-209 and thallium-205. Some of the other isotopes have been detected in nature, originating from trace quantities of 237Np produced by the (n,2n) knockout reaction in primordial 238U. This series terminates with the stable isotope thallium-205, 8 alpha decays and 4 beta decays from neptunium. The neptunium series is fairly unique among the 4, for several reasons:

, which may allow to redefine the distributions as simple functions of the age only. If the flow is steady (but a generalization to non-steady flow is possible) and is conservative, then the exit age distribution and the internal age distribution can be related one to the other:

Steiner believed that nationalism is too inherently violent to satisfy the moral prerogative of Judaism, having said "that because of what we are, there are things we can't do " and has suggested that Nazism was Europe's revenge on the Jews for inventing conscience; father of David Steiner (academic); executive director of the Johns Hopkins Institute for Education Policy; appointed to the Practitioner Council at the Hoover Institute, Stanford University. Hillel Steiner (born 1942) is a prolific author, scholar, academic, editor and political philosopher and is Emeritus Professor of Political Philosophy at the University of Manchester; signatory to the Euston Manifesto and elected to the Fellowship of the British Academy in 1999. He is a member of the following organisations: American Philosophical Association, Aristotelian Society, International Association for the Philosophy of Law and Social Philosophy, Basic Income Earth Network. British Philosophical Association, European Society for the History of Economic Thought, Political Studies Association, Society for Applied Philosophy, and the September Group.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.

Is cardarine a steroid?

No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.

Why was cardarine not developed further?

Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.

How is cardarine detected in samples?

Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.

Network